Bottom line
What is IBALX's expense ratio?
IBALX's expense ratio is 0.95%, or about $95 a year on every $10,000 invested. That is more expensive than 55% of allocation / balanced funds we track (median 0.91%). This share class also charges a front-end sales load of up to 5.5%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Feb 27, 2026
IBALX fee table
| Net expense ratio | 0.95% |
|---|---|
| Gross expense ratio | 0.95% |
| Management fee | 0.59% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.11% |
| Max front-end sales load | 5.5% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Feb 27, 2026
What IBALX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| IBALX | $642 | $836 | $1,047 | $1,652 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.95% expense ratio costs roughly $52,800 in lost growth, versus about $50,800 for the median allocation / balanced fund (0.91%).
Cheaper alternatives to IBALX
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.